Frankenius Equity AB - 31 Jul 2025 SCHEDULE 13D/A Report for TriSalus Life Sciences, Inc. Common Stock, $0.0001 par value (TLSI)

Filing Manager: Frankenius Equity AB
Reporting Manager: Frankenius Equity AB
Security: TriSalus Life Sciences, Inc. Common Stock, $0.0001 par value
Symbol: TLSI
Shares outstanding: 49,926,771 shares
Disclosed Ownership: 6,989,748 shares
Ownership: 14%
Form type: SCHEDULE 13D/A
Filing time: 04 Aug 2025, 07:33:25 UTC
Date of event: 31 Jul 2025
Previous filing: 02 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Frankenius Equity AB	14%	6,989,748	0	6,989,748	/s/ Paul Frankenius	Paul Frankenius	0001988262
Paul Frankenius	14%	6,989,748	6,989,748	0	/s/ Paul Frankenius	Paul Frankenius